Journal of Plastic Surgery and Hand Surgery
In a statement, the company accused Hims of attempting to unlawfully mass-market an unapproved, inauthentic, and untested knockoff semaglutide pill, calling the move illegal mass compounding that poses a significant risk to patient safety. Novo pledged to take legal and regulatory action to protect patients, our intellectual property and the integrity of the US gold-standard drug approval framework. On a call with analysts that same day, Novo Nordisk CEO Mike Doustdar argued that consumers would be wasting $49 on the Hims product because, without Novos proprietary SNAC technology, the pill just simply doesnt work. Former FDA Commissioner Dr
Convection-enhanced delivery of carboplatin PLGA nanoparticles for the treatment of glioblastoma
The flow rate was maintained at 300 nL/min
Small amount with noticeable results: Most patients require no more than 1 cc to see a significant improvement
- Short Term Benefit: Rapid detoxification and increased vitality
.webp)
